Ilya Yuffa

Equibles does not estimate personal net worth.

Get an email with a short summary when ELI LILLY & Co publishes a filing, an earnings call transcript or a press release.

Get LLY alerts

About Ilya Yuffa

Ilya Yuffa has spoken on 2 earnings calls and 1 other investor event across 1 company, most recently for ELI LILLY & Co on September 14, 2026. ELI LILLY & Co is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at ELI LILLY & Co includes Juan Luciano (CEO), David Ricks (Chairman and Board Member), Kimberly Johnson (COO) and 6 others.

Ilya Yuffa on recent calls

“Well, listen, we're equally excited about what we do in obesity. Obviously, as we think about long-term portfolio, we think about how do we ensure that we cover different needs from different populations.”

Other, Morgan Stanley 24th Annual Global Healthcare Conference · September 14, 2026

“Obviously, we're excited about having Part D access starting to activate for obesity medicines starting in July. In the way that we think about it, there are millions of Part D beneficiaries that are .”

Other, ELI LILLY & Co Q1 FY2026 Earnings Call · April 30, 2026

“Obviously, we start the year roughly on balance, relatively stable. There are some employers adding coverage, some removing some coverage, but we're putting additional focus in the employer space.”

Other, ELI LILLY & Co Q4 FY2025 Earnings Call · February 4, 2026